A team of investigators sought to assess the association between consumptive coagulopathy, as reflected by a prolonged prothrombin time, and host response aberrations in patients admitted to the intensive care unit with sepsis.
As the COVID-19 pandemic continues, its toll has extended beyond physical and into the emotional realm. A recent study in JAMA Network Open suggested that the prevalence of depression symptoms in the United States was more than 3 times as great during the presence of COVID-19 as it was prior to the pandemic.¹ Americans are…
Patients who speak Spanish primarily or exclusively have a unique set of struggles and barriers when getting medical care, whether as a patient or caregiver. A language barrier can be stressful and burdensome for parents trying to get help for their child. What can be done about this? A recent study from Academic Pediatrics examined…
A team of investigators sought to determine the ability of abatacept to decrease the risk of severe acute graft-vs-host disease in patients undergoing unrelated donor allogeneic hematopoietic cell transplant.
This study sought to identify trends in industry payments to medical oncologists between 2014 and 2019 to determine if the Open Payments program, which has published data on industry-physician financial interactions since 2013, was associated with changes in the frequency or value of payments.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
The Office for Civil Rights in the US Department of Health and Human Services announced proposed changes to strengthen patients’ rights to access their own health information, improve care coordination, and reduce regulatory burdens.
A team of investigators conducted a systematic literature review and meta-analysis to determine the effectiveness of combined calcium channel blocker and chelation therapy for reducing iron overload in patients with thalassemia.
The FDA is alerting clinical laboratory staff and health care providers regarding the risk of false negative results with any SARS-CoV-2 test if a mutation occurs in the part of the virus’ genome assessed by that test.
To accommodate patients remotely during the COVID-19 pandemic, practices may have expanded personnel access to protected health information and relied on devices that might be vulnerable to cyber attacks.